Gasification and combustion of the footwear leather wastes

Marcelo Godinho, Nilson Romeu Marcílio, Antônio Cézar Faria Vilela, L. Masotti, C.B. Martins

Journal of the American Leather Chemists Association · 2007 · 21 citations · 0 references

Concepts

Abstract

Chemohormonal therapy with estramustine phosphate plus LHRH agonist showed longer clinical progression-free survival than the hormonal therapy with flutamide plus LHRH agonist (P = 0.03), although there was no significant difference in the overall survival. A larger-scaled trial with more statistical power is required to clarify that the former regimen is more beneficial than the latter for newly diagnosed patients with advanced prostate cancer.